— Know what they know.
Not Investment Advice

VIR NASDAQ

Vir Biotechnology, Inc.
1W: -0.7% 1M: -15.4% 3M: +19.4% YTD: +52.0% 1Y: +90.9% 3Y: -63.7% 5Y: -78.6%
$9.19
+0.16 (+1.77%)
 
Weekly Expected Move ±6.8%
$8 $8 $9 $9 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.5B mcap · 129M float · 2.72% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.6 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -74.5%  ·  5Y Avg: -16.9%
Cost Advantage
45
Intangibles
55
Switching Cost
29
Network Effect
22
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VIR has No discernible competitive edge (36.6/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -74.5% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$23
Low
$23
Avg Target
$23
High
Based on 1 analyst since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$21.50
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Morgan Stanley $24 $23 -1 +145.3% $9.38
2026-03-04 H.C. Wainwright Patrick Trucchio $15 $20 +5 +119.1% $9.13
2026-02-26 Leerink Partners Roanna Ruiz Initiated $20 +114.5% $9.32
2026-02-24 Barclays $26 $30 +4 +216.1% $9.49
2026-02-24 Evercore ISI Cory Kasimov Initiated $18 +85.6% $9.70
2026-02-24 Needham Joseph Stringer $35 $18 -17 +86.7% $9.64
2026-02-24 Morgan Stanley Michael Ulz $20 $24 +4 +223.0% $7.43
2026-02-24 Raymond James Sean McCutcheon $12 $19 +7 +96.1% $9.69
2026-02-17 Barclays $24 $26 +2 +248.1% $7.47
2026-02-04 Barclays Etzer Darout $28 $24 -4 +212.5% $7.68
2025-12-30 H.C. Wainwright Patrick Trucchio Initiated $15 +150.8% $5.98
2025-07-11 Raymond James Sean McCutcheon Initiated $12 +112.4% $5.65
2025-01-09 Morgan Stanley Michael Ulz $15 $20 +5 +153.5% $7.89
2024-08-02 Barclays Gena Wang $27 $28 +1 +187.8% $9.73
2024-06-05 Morgan Stanley Michael Ulz Initiated $15 +18.5% $12.66
2024-05-21 Barclays Gena Wang Initiated $27 +178.6% $9.69
2022-05-06 Needham Joseph Stringer Initiated $35 +60.0% $21.87

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VIR receives an overall rating of C. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-24 C- C
2026-04-01 C C-
2026-02-24 D+ C
2026-02-23 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
85
Earnings Quality
76
Growth
86
Value
40
Momentum
79
Safety
15
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.73
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
Ohlson O-Score
-4.22
Bankruptcy prob: 1.5%
Low Risk
Credit Rating
BB+
Score: 47.9/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 1.01x
Accruals: 0.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VIR scores 0.73, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VIR scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VIR's implied 1.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VIR receives an estimated rating of BB+ (score: 47.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.06x
PEG
-0.10x
P/S
23.66x
P/B
1.67x
P/FCF
-2.97x
P/OCF
EV/EBITDA
-2.34x
EV/Revenue
15.95x
EV/EBIT
-2.28x
EV/FCF
-2.35x
Earnings Yield
-33.53%
FCF Yield
-33.69%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. VIR currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.001
NI / EBT
×
Interest Burden
0.966
EBT / EBIT
×
EBIT Margin
-6.990
EBIT / Rev
×
Asset Turnover
0.055
Rev / Assets
×
Equity Multiplier
1.254
Assets / Equity
=
ROE
-46.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VIR's ROE of -46.2% is driven by Asset Turnover (0.055), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1662 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$9.19
Median 1Y
$5.69
5th Pctile
$1.12
95th Pctile
$28.69
Ann. Volatility
91.4%
Analyst Target
$21.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marianne De Backer,
M.Sc., Ph.D., MBA President, Chief Executive Officer and Director
$950,000 $2,296,800 $7,834,045
Mark Eisner, M.D.,
M.P.H Executive Vice President and Chief Medical Officer
$660,833 $382,800 $2,371,484
Jason O’Byrne, MBA
Executive Vice President and Chief Financial Officer
$534,417 $382,800 $1,951,828
Vanina de Verneuil,
J.D. Executive Vice President, General Counsel and Corporate Secretary
$506,333 $334,950 $1,690,784

CEO Pay Ratio

31:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,834,045
Avg Employee Cost (SGA/emp): $250,883
Employees: 367

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
367
-10.1% YoY
Revenue / Employee
$186,801
Rev: $68,556,000
Profit / Employee
$-1,193,425
NI: $-437,987,000
SGA / Employee
$250,883
Avg labor cost proxy
R&D / Employee
$1,179,281
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -52.1% -17.9% 49.2% 1.1% 1.0% 1.1% 29.4% -8.2% -14.9% -34.2% -33.5% -29.4% -26.3% -29.1% -38.1% -42.2% -40.2% -36.5% -45.7% -46.2% -46.22%
ROA -41.6% -14.3% 36.8% 84.7% 75.0% 79.5% 21.7% -6.0% -11.0% -25.3% -26.1% -22.9% -20.5% -22.6% -31.5% -34.8% -33.2% -30.1% -36.5% -36.9% -36.87%
ROIC -4.6% -4.1% 47.0% 1.4% 1.2% 1.4% -2.9% 1.3% 1.3% 2.8% -2.8% -2.6% -2.3% -2.5% -1.4% -1.5% -1.4% -1.3% -75.6% -74.5% -74.53%
ROCE -35.8% -31.6% 28.5% 1.0% 83.5% 98.9% 36.4% -14.1% -13.5% -30.0% -38.3% -34.6% -30.1% -32.1% -41.6% -46.3% -45.3% -40.9% -50.9% -50.3% -50.31%
Gross Margin 50.7% -2.8% 77.2% 85.4% 4.5% 63.6% -2.3% -1.5% -43.3% -54.0% -5.3% -74.8% -33.2% -81.0% -6.2% -37.8% -79.3% -630.0% 6.7% 97.9% 97.93%
Operating Margin 34.5% -51.5% 70.3% 82.3% 5.5% 52.1% -3.0% -2.3% -56.7% -70.8% -8.3% -1.4% -51.6% -97.2% -9.5% -46.0% -97.5% -722.7% -57.1% 4592.4% 4592.41%
Net Margin 34.9% 1.1% 64.6% 42.1% 1.9% 46.8% -2.1% -2.2% -51.3% -61.9% -6.9% -1.2% -45.0% -89.8% -8.5% -39.9% -91.4% -679.8% -67.0% 4334.3% 4334.31%
EBITDA Margin 35.3% -50.1% 75.4% 82.4% 5.5% 52.5% -3.0% -2.2% -54.0% -67.7% -7.5% -1.3% -41.7% -90.6% -8.1% -44.7% -95.3% -666.6% -62.7% 4495.5% 4495.48%
FCF Margin -49.4% -52.7% -6.3% 23.9% 64.3% 65.9% 98.7% 2.1% -83.5% -5.6% -9.3% -9.8% -5.8% -6.0% -6.1% -20.2% -24.5% -27.3% -5.7% -6.8% -6.79%
OCF Margin -45.7% -48.8% -4.3% 25.5% 67.0% 68.8% 1.0% 2.2% -73.8% -5.4% -9.0% -9.6% -5.7% -5.9% -6.0% -19.9% -24.1% -26.9% -5.7% -6.8% -6.81%
ROE 3Y Avg snapshot only -47.33%
ROE 5Y Avg snapshot only -12.79%
ROA 3Y Avg snapshot only -37.85%
ROIC 3Y Avg snapshot only -56.07%
ROIC Economic snapshot only -38.35%
Cash ROA snapshot only -44.48%
Cash ROIC snapshot only -91.16%
CROIC snapshot only -90.90%
NOPAT Margin snapshot only -5.57%
Pretax Margin snapshot only -6.75%
R&D / Revenue snapshot only 6.81%
SGA / Revenue snapshot only 1.06%
SBC / Revenue snapshot only 53.46%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -21.27 -56.93 10.60 2.85 3.13 2.28 6.53 -21.63 -12.55 -2.09 -2.20 -2.54 -2.51 -1.92 -1.92 -1.54 -1.27 -1.59 -1.92 -2.98 -3.059
P/S Ratio 35.50 20.69 5.12 1.49 1.60 1.09 2.09 6.96 6.70 10.59 15.71 17.22 15.37 13.02 13.53 42.70 36.72 47.05 12.25 20.16 23.665
P/B Ratio 8.82 8.13 3.91 2.42 2.36 1.82 1.62 1.50 1.58 0.61 0.85 0.86 0.76 0.64 0.87 0.77 0.61 0.69 1.10 1.73 1.666
P/FCF -71.87 -39.22 -80.76 6.23 2.49 1.66 2.11 3.35 -8.02 -1.88 -1.69 -1.76 -2.64 -2.16 -2.21 -2.11 -1.50 -1.72 -2.14 -2.97 -2.968
P/OCF 5.84 2.39 1.59 2.03 3.15
EV/EBITDA -19.65 -20.34 10.80 1.76 2.07 1.27 1.31 -2.66 -3.44 1.52 0.07 0.05 0.37 0.69 -0.38 -0.14 0.19 0.03 -1.25 -2.34 -2.341
EV/Revenue 31.76 18.32 4.60 1.24 1.33 0.85 0.68 1.87 2.07 -8.55 -0.51 -0.35 -2.35 -4.76 2.65 4.00 -5.77 -0.84 8.22 15.95 15.946
EV/EBIT -19.27 -19.89 10.94 1.77 2.08 1.27 1.32 -2.57 -3.29 1.48 0.07 0.05 0.35 0.67 -0.37 -0.14 0.19 0.03 -1.22 -2.28 -2.281
EV/FCF -64.30 -34.73 -72.54 5.21 2.07 1.30 0.69 0.90 -2.47 1.52 0.05 0.04 0.40 0.79 -0.43 -0.20 0.24 0.03 -1.44 -2.35 -2.348
Earnings Yield -4.7% -1.8% 9.4% 35.1% 31.9% 43.9% 15.3% -4.6% -8.0% -47.7% -45.4% -39.4% -39.8% -52.1% -52.0% -64.8% -78.9% -63.0% -52.2% -33.5% -33.53%
FCF Yield -1.4% -2.5% -1.2% 16.0% 40.2% 60.2% 47.3% 29.9% -12.5% -53.1% -59.1% -56.8% -37.8% -46.2% -45.2% -47.4% -66.8% -58.0% -46.7% -33.7% -33.69%
Price/Tangible Book snapshot only 1.783
EV/Gross Profit snapshot only 5.793
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.80 7.80 4.58 4.58 4.58 4.58 4.93 4.93 4.93 4.93 9.05 9.05 9.05 9.05 8.71 8.71 8.71 8.71 5.54 5.54 5.539
Quick Ratio 7.80 7.80 4.58 4.58 4.58 4.58 4.93 4.93 4.93 4.93 9.05 9.05 9.05 9.05 8.71 8.71 8.71 8.71 5.54 5.54 5.539
Debt/Equity 0.10 0.10 0.10 0.10 0.10 0.10 0.06 0.06 0.06 0.06 0.08 0.08 0.08 0.08 0.09 0.09 0.09 0.09 0.24 0.24 0.244
Net Debt/Equity -0.93 -0.93 -0.40 -0.40 -0.40 -0.40 -1.09 -1.09 -1.09 -1.09 -0.88 -0.88 -0.88 -0.88 -0.70 -0.70 -0.70 -0.70 -0.36 -0.36 -0.361
Debt/Assets 0.08 0.08 0.07 0.07 0.07 0.07 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.06 0.07 0.07 0.07 0.07 0.19 0.19 0.186
Debt/EBITDA -0.24 -0.28 0.29 0.08 0.10 0.09 0.15 -0.41 -0.43 -0.19 -0.19 -0.21 -0.25 -0.23 -0.19 -0.17 -0.17 -0.19 -0.41 -0.42 -0.419
Net Debt/EBITDA 2.32 2.63 -1.22 -0.35 -0.42 -0.36 -2.71 7.26 7.72 3.39 2.16 2.39 2.76 2.57 1.56 1.39 1.42 1.58 0.61 0.62 0.618
Interest Coverage
Equity Multiplier 1.28 1.28 1.36 1.36 1.36 1.36 1.35 1.35 1.35 1.35 1.21 1.21 1.21 1.21 1.22 1.22 1.22 1.22 1.31 1.31 1.310
Cash Ratio snapshot only 4.987
Cash to Debt snapshot only 2.476
FCF to Debt snapshot only -2.380
Defensive Interval snapshot only 265.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.25 0.39 0.76 1.62 1.47 1.66 0.68 0.19 0.21 0.05 0.04 0.03 0.03 0.03 0.04 0.01 0.01 0.01 0.06 0.05 0.055
Inventory Turnover
Receivables Turnover 2.83 6.02 5.45 6.15 4.18 1.15 1.27 0.31 38.09 36.39 36.386
Payables Turnover 15.93 35.37 65.35 96.46 106.07 111.23 95.95 92.74 96.61 97.95 90.79 81.23 71.36 79.22 85.45 88.79 87.46 79.79 0.00 -15.42
DSO 0 0 129 61 67 59 87 316 288 1188 0 0 0 0 0 0 0 0 10 10 10.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DPO 23 10 6 4 3 3 4 4 4 4 4 4 5 5 4 4 4 5 104474
Cash Conversion Cycle -23 -10 123 57 63 56 84 312 284 1184 -4 -4 -5 -5 -4 -4 -4 -5 -104465
Fixed Asset Turnover snapshot only 0.556
Cash Velocity snapshot only 0.142
Capital Intensity snapshot only 15.311
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.4% 2.8% 14.1% 33.5% 10.8% 7.4% 47.7% -80.8% -76.7% -95.0% -94.7% -82.2% -83.9% -33.8% -13.9% -73.8% -75.9% -78.6% -7.6% 2.1% 2.14%
Net Income -72.7% 60.2% 2.8% 4.1% 4.6% 12.2% -2.4% -1.1% -1.2% -1.5% -2.2% -2.8% -84.4% 11.2% 15.1% -7.1% -13.9% 6.3% 16.1% 23.4% 23.36%
EPS -48.4% 62.5% 2.7% 4.0% 4.7% 12.1% -1.9% -1.1% -1.2% -1.5% -2.2% -2.7% -81.4% 12.7% 16.5% -5.4% -12.1% 7.9% 17.5% 28.5% 28.50%
FCF 13.8% 3.2% 64.9% 3.3% 16.4% 11.6% 24.0% 67.3% -1.3% -1.4% -1.5% -1.8% -11.9% 29.2% 43.3% 45.8% -1.7% 2.7% 13.6% -5.4% -5.37%
EBITDA -85.6% -5.1% 2.6% 5.3% 5.7% 7.3% 80.2% -1.2% -1.2% -1.4% -1.8% -86.5% -72.1% 18.8% 20.1% 0.8% -11.9% 6.0% 12.8% 23.0% 23.03%
Op. Income -78.3% -2.8% 2.4% 5.2% 5.5% 7.0% 98.0% -1.2% -1.2% -1.4% -1.8% -91.6% -79.7% 12.5% 14.2% -4.1% -7.4% 9.9% 20.3% 28.6% 28.61%
OCF Growth snapshot only -7.46%
Asset Growth snapshot only -28.31%
Equity Growth snapshot only -33.48%
Debt Growth snapshot only 90.93%
Shares Change snapshot only 7.19%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 10.8% 3.1% 88.8% 17.5% 5.9% 5.7% -23.8% -34.6% -59.2% -79.2% -79.2% -80.8% -65.1% -47.3% -47.25%
Revenue 5Y 1.4% 25.5% -23.6% -25.4% -1.1% -0.6% -0.56%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -59.0%
Gross Profit 5Y 36.1% 21.8% 21.76%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 76.2% 76.2% 76.2% 76.2% 27.8% 27.8% 27.8% 27.8% -10.5% -10.5% -10.5% -10.5% -29.0% -29.0% -29.00%
Assets 5Y 22.3% 22.3% 22.3% 22.3% 1.8% 1.8% 1.77%
Equity 3Y 69.9% 69.9% 69.9% 69.9% 30.4% 30.4% 30.4% 30.4% -7.0% -7.0% -7.0% -7.0% -28.3% -28.3% -28.32%
Book Value 3Y 50.1% 58.4% 61.4% 66.2% 28.0% 28.0% 29.6% 29.5% -7.7% -7.7% -8.4% -7.9% -29.4% -30.6% -30.63%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.80 0.77 0.79 0.82 0.92 0.18 0.19 0.07 0.01 0.05 0.07 0.11 0.00 0.05 0.06 0.06 0.05 0.07 0.072
Earnings Stability 0.48 0.62 0.68 0.83 0.63 0.08 0.05 0.00 0.01 0.02 0.02 0.06 0.12 0.10 0.11 0.12 0.26 0.22 0.222
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.97 0.94 0.97 0.94 0.91 0.907
Earnings Smoothness 0.98
ROE Trend 0.65 1.29 1.16 1.17 0.27 -0.22 -0.30 -0.62 -0.70 -0.73 -0.62 -0.59 -0.38 -0.30 -0.26 -0.12 -0.15 -0.16 -0.158
Gross Margin Trend 27.48 8.09 0.72 0.84 0.19 -1.22 -0.88 -4.86 -6.35 -5.72 -4.99 -3.62 -3.02 -20.37 -22.75 -21.13 6.65 17.15 17.154
FCF Margin Trend 21.93 8.73 1.59 1.97 2.38 3.73 -0.91 -5.69 -9.75 -10.95 -5.72 -3.53 -1.96 -16.38 -21.22 -21.49 1.99 8.22 8.219
Sustainable Growth Rate 49.2% 1.1% 1.0% 1.1% 29.4%
Internal Growth Rate 58.2% 5.5% 3.0% 3.9% 27.7%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.27 1.34 -0.09 0.49 1.31 1.43 3.22 -6.87 1.38 1.06 1.27 1.41 0.93 0.87 0.86 0.72 0.83 0.91 0.89 1.01 1.008
FCF/OCF 1.08 1.08 1.46 0.94 0.96 0.96 0.96 0.94 1.13 1.05 1.03 1.02 1.02 1.01 1.02 1.02 1.02 1.02 1.00 1.00 0.997
FCF/Net Income snapshot only 1.005
CapEx/Revenue 3.7% 4.0% 2.0% 1.6% 2.6% 2.9% 4.2% 13.2% 9.8% 27.5% 25.0% 20.8% 9.9% 8.2% 9.8% 33.8% 47.0% 40.9% 0.0% 1.9% 1.89%
CapEx/Depreciation snapshot only 0.107
Accruals Ratio -0.30 0.05 0.40 0.43 -0.23 -0.34 -0.48 -0.48 0.04 0.01 0.07 0.09 -0.01 -0.03 -0.05 -0.10 -0.06 -0.03 -0.04 0.00 0.003
Sloan Accruals snapshot only -0.427
Cash Flow Adequacy snapshot only -360.009
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -6.5% -3.1% -3.3% -3.7% -3.7% -1.5% -1.1% -0.3% -0.3% -0.6% -0.6% -0.4% -0.4% -0.5% -0.3% -0.3% -0.4% -0.3% -0.4% -12.6% -12.58%
Total Shareholder Return -6.5% -3.1% -3.3% -3.7% -3.7% -1.5% -1.1% -0.3% -0.3% -0.6% -0.6% -0.4% -0.4% -0.5% -0.3% -0.3% -0.4% -0.3% -0.4% -12.6% -12.58%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.01 0.96 0.74 0.80 0.79 0.68 0.46 0.95 0.91 0.98 0.98 0.98 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.001
Interest Burden (EBT/EBIT) 1.01 0.39 1.19 1.00 1.00 0.91 0.91 0.96 0.89 0.96 0.94 0.91 0.94 0.96 0.98 0.98 0.95 0.95 0.95 0.97 0.966
EBIT Margin -1.65 -0.92 0.42 0.70 0.64 0.67 0.52 -0.73 -0.63 -5.78 -7.74 -7.57 -6.66 -7.13 -7.18 -28.41 -30.46 -31.03 -6.76 -6.99 -6.990
Asset Turnover 0.25 0.39 0.76 1.62 1.47 1.66 0.68 0.19 0.21 0.05 0.04 0.03 0.03 0.03 0.04 0.01 0.01 0.01 0.06 0.05 0.055
Equity Multiplier 1.25 1.25 1.34 1.34 1.34 1.34 1.36 1.36 1.36 1.36 1.29 1.29 1.29 1.29 1.21 1.21 1.21 1.21 1.25 1.25 1.254
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.22 $-0.76 $3.95 $9.04 $8.14 $8.47 $3.87 $-1.08 $-1.95 $-4.47 $-4.57 $-3.99 $-3.55 $-3.90 $-3.82 $-4.20 $-3.97 $-3.60 $-3.15 $-3.00 $-3.00
Book Value/Share $5.36 $5.36 $10.70 $10.64 $10.81 $10.61 $15.61 $15.56 $15.50 $15.47 $11.81 $11.76 $11.67 $11.64 $8.41 $8.37 $8.31 $8.28 $5.50 $5.19 $5.52
Tangible Book/Share $4.98 $4.98 $10.32 $10.27 $10.43 $10.24 $15.23 $15.19 $15.13 $15.10 $11.52 $11.46 $11.38 $11.35 $8.23 $8.19 $8.13 $8.10 $5.32 $5.03 $5.03
Revenue/Share $1.33 $2.10 $8.17 $17.29 $15.92 $17.63 $12.13 $3.34 $3.66 $0.88 $0.64 $0.59 $0.58 $0.58 $0.54 $0.15 $0.14 $0.12 $0.49 $0.44 $0.44
FCF/Share $-0.66 $-1.11 $-0.52 $4.13 $10.24 $11.61 $11.98 $6.95 $-3.06 $-4.98 $-5.95 $-5.76 $-3.37 $-3.46 $-3.32 $-3.07 $-3.37 $-3.31 $-2.81 $-3.02 $-3.02
OCF/Share $-0.61 $-1.03 $-0.36 $4.40 $10.66 $12.12 $12.49 $7.39 $-2.70 $-4.73 $-5.79 $-5.64 $-3.31 $-3.41 $-3.26 $-3.02 $-3.30 $-3.26 $-2.81 $-3.03 $-3.03
Cash/Share $5.51 $5.50 $5.29 $5.26 $5.35 $5.25 $18.04 $17.99 $17.92 $17.89 $11.31 $11.25 $11.17 $11.14 $6.62 $6.59 $6.54 $6.52 $3.32 $3.14 $3.21
EBITDA/Share $-2.15 $-1.89 $3.48 $12.18 $10.21 $11.86 $6.31 $-2.35 $-2.20 $-4.99 $-4.81 $-4.32 $-3.72 $-3.98 $-3.79 $-4.22 $-4.10 $-3.68 $-3.24 $-3.03 $-3.03
Debt/Share $0.52 $0.52 $1.03 $1.02 $1.04 $1.02 $0.96 $0.96 $0.95 $0.95 $0.93 $0.92 $0.91 $0.91 $0.72 $0.71 $0.71 $0.70 $1.34 $1.27 $1.27
Net Debt/Share $-4.98 $-4.98 $-4.26 $-4.24 $-4.31 $-4.23 $-17.08 $-17.03 $-16.96 $-16.93 $-10.38 $-10.33 $-10.26 $-10.23 $-5.90 $-5.87 $-5.83 $-5.81 $-1.98 $-1.87 $-1.87
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.726
Altman Z-Prime snapshot only 1.630
Piotroski F-Score 4 4 4 5 7 7 7 5 2 3 1 2 3 2 2 1 1 1 4 2 2
Beneish M-Score -1.50 469.04 2407.39 1816.01 -1.36 -7.06 -7.16 -4.96 -2.51 -1.01 -2.10 -2.44 -2.77 -4.12 -3.37 -3.63 0.38
Ohlson O-Score snapshot only -4.216
ROIC (Greenblatt) snapshot only -84.94%
Net-Net WC snapshot only $1.88
EVA snapshot only $-413638070.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 74.02 73.71 86.84 94.60 94.95 94.95 95.23 78.25 73.86 54.30 60.06 59.69 59.91 54.15 54.09 50.10 49.83 49.52 42.67 47.87 47.868
Credit Grade snapshot only 11
Credit Trend snapshot only -2.233
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 45
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms